Affinage

COQ4

Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial · UniProt Q9Y3A0

Length
265 aa
Mass
29.7 kDa
Annotated
2026-06-09
25 papers in source corpus 10 papers cited in narrative 10 extracted findings
Cross-family judge vs UniProt: tie faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

COQ4 is a mitochondrial inner-membrane-associated protein with dual roles in coenzyme Q (CoQ/ubiquinone) biosynthesis, functioning both as a direct biosynthetic enzyme and as the structural organizer of the multi-enzyme COQ complex (PMID:19022396, PMID:38295803). As an enzyme, COQ4 catalyzes the oxidative decarboxylation of the C1 carbon of CoQ precursors, an activity it retains when expressed heterologously in E. coli deficient for C1 decarboxylation and in the non-CoQ-producing Corynebacterium glutamicum; consistent with this step, COQ4-deficient patient fibroblasts accumulate the intermediate 6-demethoxyubiquinone while CoQ10 falls (PMID:38295803, PMID:34656997). Independently of its catalytic activity, COQ4 nucleates a high-molecular-mass multiheteromeric complex co-migrating with Coq3p and Coq7p, and point mutants disrupt this assembly without lowering subunit abundance (PMID:19022396). Human COQ4 isoform 1 carries a functional N-terminal mitochondrial targeting sequence required for mitochondrial localization, and it complements COQ4-null yeast, restoring growth on non-fermentable carbon and CoQ content (PMID:18474229, PMID:11469793). Loss of COQ4 reduces CoQ10 and CoQ10-dependent respiratory chain complex II+III activity, and uniquely among CoQ biosynthesis genes haploinsufficiency alone is sufficient to cause CoQ deficiency (PMID:22368301, PMID:25658047). Downstream consequences include mitochondrial ROS accumulation and loss of membrane potential, and in vivo COQ4 loss produces motor and cerebellar-region developmental defects in zebrafish and embryonic lethality with placental vascular failure in mice linked to the FSP1/CoQ10 antioxidant axis (PMID:38014483, PMID:33704555, PMID:41847387).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2001 Medium

    Established where COQ4 acts and that it is functionally coupled to other CoQ biosynthetic components, answering whether it is membrane-associated and connected to the pathway machinery.

    Evidence Subcellular fractionation, in vitro mitochondrial import assay, and Western blot in yeast

    PMID:11469793

    Open questions at the time
    • Did not define a catalytic or structural mechanism
    • Dependency on Coq7p levels was correlative, not mechanistic
  2. 2008 High

    Defined COQ4's role as the organizer of a multi-enzyme CoQ biosynthetic complex, distinguishing a scaffolding function from subunit stabilization.

    Evidence Blue Native PAGE, gel filtration, and O-methyltransferase activity assays on yeast mitochondrial extracts with E226K/E121K point mutants

    PMID:19022396

    Open questions at the time
    • Did not establish whether COQ4 has its own catalytic activity
    • Complex stoichiometry and architecture undefined
  3. 2008 High

    Confirmed that human COQ4 is the functional ortholog and mapped its mitochondrial targeting to isoform 1's N-terminal sequence, establishing the relevant human gene product.

    Evidence GFP-fusion live imaging in HeLa cells and functional complementation of COQ4-null yeast

    PMID:18474229

    Open questions at the time
    • Function of isoform 2 unresolved
    • Did not address enzymatic versus structural role
  4. 2012 High

    Showed that COQ4 dosage is uniquely rate-limiting, since haploinsufficiency alone causes CoQ deficiency and respiratory impairment unlike other pathway genes.

    Evidence CoQ10 content and biosynthetic rate assays, respiratory chain enzyme activity in patient fibroblasts, siRNA knockdown in HeLa, yeast haploinsufficiency model

    PMID:22368301

    Open questions at the time
    • Mechanistic basis of unique dosage sensitivity unexplained
    • Did not localize the affected biosynthetic step
  5. 2015 High

    Demonstrated that pathogenic human COQ4 mutations are loss-of-function and reinforced the structural stabilization role for the biosynthetic complex.

    Evidence Yeast oxidative-growth complementation with multiple human mutations plus CoQ10 and ETC measurements in patient specimens

    PMID:25658047

    Open questions at the time
    • Did not separate structural from catalytic contributions of individual residues
  6. 2021 Medium

    Placed COQ4 activity at a specific biosynthetic step by showing accumulation of the 6-demethoxyubiquinone intermediate upon deficiency.

    Evidence Biochemical metabolite profiling and COQ4 Western blot in patient-derived fibroblasts

    PMID:34656997

    Open questions at the time
    • Intermediate accumulation was correlative and did not directly prove enzymatic catalysis
    • Single-lab metabolite measurement
  7. 2021 Medium

    Provided in vivo evidence that COQ4 is required for brain development, linking the molecular deficiency to a cerebellar-analogous neuronal phenotype.

    Evidence CRISPR F0 zebrafish crispants with motor behavioral assay and hindbrain histology

    PMID:33704555

    Open questions at the time
    • F0 crispant mosaicism limits genotype-phenotype precision
    • Did not connect phenotype to specific biosynthetic defect
  8. 2023 Medium

    Connected COQ4 loss to downstream mitochondrial dysfunction (ROS, membrane potential loss) and reinforced the in vivo motor phenotype.

    Evidence ROS and membrane potential assays and ubiquinone quantification in patient fibroblasts and knockout complementation lines plus zebrafish knockdown motor assay

    PMID:38014483

    Open questions at the time
    • Knockdown rather than complete knockout in zebrafish
    • Single study
  9. 2024 High

    Resolved the long-standing question of whether COQ4 is enzymatic by demonstrating direct oxidative decarboxylation of the C1 carbon of CoQ precursors.

    Evidence Heterologous complementation in E. coli deficient for C1 decarboxylation/hydroxylation and activity assay in Corynebacterium glutamicum with metabolite analysis

    PMID:38295803

    Open questions at the time
    • Catalytic residues and reaction chemistry not structurally defined
    • Relationship between catalytic and scaffolding roles within the complex not fully integrated
  10. 2026 Medium

    Extended COQ4 function to an organismal antioxidant role, linking its deficiency to placental vascular failure via the FSP1/CoQ10 axis and ferroptosis.

    Evidence CRISPR Coq4+/- and Coq4-/- mice, placental histology/IF, HUVEC knockdown, RNA-seq, ferroptosis marker Western blots, and FSP1/CoQ10 rescue

    PMID:41847387

    Open questions at the time
    • Ferroptosis link based on markers and rescue, not direct death assays
    • Single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • How COQ4's catalytic decarboxylase activity and its structural complex-organizing role are coordinated within the mitochondrial COQ complex remains unresolved.
  • No structural model of human COQ4 or the COQ complex
  • Stoichiometry and substrate channeling within the complex undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2 GO:0016829 lyase activity 1 GO:0140096 catalytic activity, acting on a protein 1
Localization
GO:0005739 mitochondrion 2
Pathway
R-HSA-1430728 Metabolism 2
Partners
Complex memberships
COQ biosynthetic complex

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2001 Yeast Coq4p peripherally associates with the matrix face of the mitochondrial inner membrane, is imported via a mitochondrial targeting sequence in a membrane-potential-dependent manner, and its presence is required to maintain steady-state levels of Coq7p, another CoQ biosynthetic component. Western blot with specific antiserum, subcellular fractionation, in vitro mitochondrial import assay Archives of biochemistry and biophysics Medium 11469793
2008 Yeast Coq4p organizes a high-molecular-mass multi-enzyme complex required for CoQ biosynthesis; coq4 point mutants (E226K and E121K) disrupt co-migration of Coq3p, Coq4p, and Coq7p in this complex as shown by Blue Native-PAGE and gel filtration, without reducing steady-state levels of Coq polypeptides. Blue Native PAGE (1D and 2D), gel filtration chromatography, O-methyltransferase activity assay on digitonin-solubilized mitochondrial extracts Biochimica et biophysica acta High 19022396
2008 Human COQ4 isoform 1 (265 aa) contains a functional N-terminal mitochondrial targeting sequence and localizes to mitochondria; isoform 2 (241 aa), lacking this sequence, does not localize to mitochondria. Human COQ4 isoform 1 complements COQ4-null yeast, restoring growth on non-fermentable carbon and CoQ content. GFP-fusion protein live imaging in HeLa cells; functional complementation of COQ4-null yeast Biochemical and biophysical research communications High 18474229
2012 Haploinsufficiency of COQ4 (48% expression) reduces CoQ10 content and biosynthetic rate (~43–44% of controls) and impairs respiratory chain complex II+III activity in patient fibroblasts; knockdown of COQ4 in HeLa cells similarly reduces CoQ10. Unlike other CoQ biosynthesis genes, haploinsufficiency of COQ4 alone is sufficient to cause CoQ deficiency. Biochemical assay of CoQ10 content and biosynthetic rate; respiratory chain enzyme activity assay in patient fibroblasts; siRNA knockdown in HeLa cells; yeast haploinsufficiency model Journal of medical genetics High 22368301
2015 COQ4 plays a structural role stabilizing a multiheteromeric complex containing most CoQ10 biosynthetic enzymes; pathogenic human COQ4 mutations fail to complement COQ4-null yeast for oxidative growth, whereas wild-type human COQ4 cDNA fully rescues growth, demonstrating loss-of-function pathogenicity. Yeast complementation assay (oxidative growth rescue); reduced CoQ10 and CoQ10-dependent ETC activities measured in patient specimens American journal of human genetics High 25658047
2021 COQ4-deficient patient fibroblasts show elevated levels of the metabolic intermediate 6-demethoxyubiquinone alongside reduced CoQ10 and reduced COQ4 protein, placing COQ4 activity at the step converting 6-demethoxyubiquinone to downstream CoQ precursors. Biochemical assay of CoQ10 and 6-demethoxyubiquinone in patient-derived fibroblasts; Western blot for COQ4 protein levels Journal of medical genetics Medium 34656997
2021 Coq4 loss-of-function in zebrafish (coq4 F0 CRISPR crispants) causes motor defects and cell reduction in a specific hindbrain region analogous to the human cerebellum, demonstrating an in vivo developmental role for COQ4 in brain formation. CRISPR F0 zebrafish crispant generation; behavioral motor assay; histological analysis of hindbrain Journal of neurology Medium 33704555
2024 COQ4 catalyzes the oxidative decarboxylation of the C1 carbon of CoQ precursors in eukaryotes; it complements an E. coli strain deficient for C1 decarboxylation/hydroxylation and displays oxidative decarboxylation activity in the non-CoQ-producing organism Corynebacterium glutamicum, demonstrating that COQ4 has a direct enzymatic (not merely structural) function in CoQ biosynthesis. Heterologous complementation assay in E. coli deficient for C1 decarboxylation/hydroxylation; functional activity assay in Corynebacterium glutamicum; CoQ precursor metabolite analysis Molecular cell High 38295803
2023 COQ4 loss-of-function in patient-derived fibroblasts and COQ4 knockout complementation cell lines causes mitochondrial reactive oxygen species accumulation, decreased mitochondrial membrane potential, and reduced ubiquinone biosynthesis; coq4 knockdown in zebrafish causes severe motor dysfunction reflecting motor neuron dysregulation. ROS assay, mitochondrial membrane potential measurement, ubiquinone quantification in patient fibroblasts and knockout complementation lines; coq4 zebrafish knockdown with motor behavioral assay Movement disorders : official journal of the Movement Disorder Society Medium 38014483
2026 Coq4 deficiency disrupts placental vascular development through the FSP1/CoQ10 antioxidant axis; Coq4-/- embryos are lethal and show placental vascular rarefaction and impaired trophoblast invasion. Coq4 knockdown in HUVECs upregulates ferroptosis markers (ACSL4, FTH1) and downregulates FSP1, and FSP1 overexpression or CoQ10 supplementation partially alleviates ferroptosis. CRISPR-Cas9 Coq4+/- and Coq4-/- mouse generation; placental histology and immunofluorescence; lentiviral Coq4 knockdown in HUVECs; RNA-seq; Western blot for ferroptosis pathway proteins; rescue experiments with FSP1 overexpression and CoQ10 supplementation Frontiers in cell and developmental biology Medium 41847387

Source papers

Stage 0 corpus · 25 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2015 COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. American journal of human genetics 94 25658047
2012 Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency. Journal of medical genetics 94 22368301
2008 The yeast Coq4 polypeptide organizes a mitochondrial protein complex essential for coenzyme Q biosynthesis. Biochimica et biophysica acta 78 19022396
2001 Yeast COQ4 encodes a mitochondrial protein required for coenzyme Q synthesis. Archives of biochemistry and biophysics 61 11469793
2008 Functional characterization of human COQ4, a gene required for Coenzyme Q10 biosynthesis. Biochemical and biophysical research communications 53 18474229
2015 Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy. Journal of medical genetics 48 26185144
2017 Novel recessive mutations in COQ4 cause severe infantile cardiomyopathy and encephalopathy associated with CoQ10 deficiency. Molecular genetics and metabolism reports 31 28540186
2019 COQ4 Mutation Leads to Childhood-Onset Ataxia Improved by CoQ10 Administration. Cerebellum (London, England) 29 30847826
2021 New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts. Journal of neurology 28 33704555
2019 Clinical phenotype, in silico and biomedical analyses, and intervention for an East Asian population-specific c.370G>A (p.G124S) COQ4 mutation in a Chinese family with CoQ10 deficiency-associated Leigh syndrome. Journal of human genetics 25 30659264
2024 COQ4 is required for the oxidative decarboxylation of the C1 carbon of coenzyme Q in eukaryotic cells. Molecular cell 24 38295803
2021 Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes. Journal of medical genetics 22 34656997
2022 Bi-Allelic COQ4 Variants Cause Adult-Onset Ataxia-Spasticity Spectrum Disease. Movement disorders : official journal of the Movement Disorder Society 18 36047608
2016 Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q10 deficiency harboring a heterozygous mutation in COQ4 gene. Stem cell research 14 28465093
2022 Primary Coenzyme Q10 Deficiency-7 and Pathogenic COQ4 Variants: Clinical Presentation, Biochemical Analyses, and Treatment. Frontiers in genetics 12 35154243
2023 Biallelic COQ4 Variants in Hereditary Spastic Paraplegia: Clinical and Molecular Characterization. Movement disorders : official journal of the Movement Disorder Society 8 38014483
2023 Biallelic variants in the COQ4 gene caused hereditary spastic paraplegia predominant phenotype. CNS neuroscience & therapeutics 6 38013626
2024 The Spectrum of clinical manifestations in newborns with the COQ4 mutation: case series and literature review. Frontiers in pediatrics 3 39398416
2026 Coq4 deficiency induces placental vascular development defects through FSP1/CoQ10 axis-mediated endothelial ferroptosis. Frontiers in cell and developmental biology 1 41847387
2024 Identification of a new COQ4 spliceogenic variant causing severe primary coenzyme Q deficiency. Molecular genetics and metabolism reports 1 39759098
2023 COQ4 is required for the oxidative decarboxylation of the C1 carbon of Coenzyme Q in eukaryotic cells. bioRxiv : the preprint server for biology 1 38014142
2025 Clinical features and genotype in COQ4 associated hereditary spastic paraplegia: a case report and a literature reanalysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 0 39776381
2025 Generation of an induced pluripotent stem cell (iPSC) line (XMUi001-A) derived from a patient harboring homozygous mutations c.370G > A (p.Gly124Ser) in the COQ4 gene. Stem cell research 0 40645015
2025 CRISPR/Cas9-mediated editing of COQ4 in induced pluripotent stem cells: A model for investigating COQ4-associated human coenzyme Q10 deficiency. Stem cell research 0 40929753
2023 Epilepsy and Coenzyme Q10 deficiency with COQ4 variants. Epilepsy & behavior : E&B 0 37948995

Missed literature

Know a paper Affinage missed for COQ4? Flag it for the maintainers and the community.

No submissions yet.